Mark A Perazella
Overview
Explore the profile of Mark A Perazella including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
266
Citations
5377
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Baptista A, Macedo A, Marreiros A, Coelho A, Perazella M
J Clin Med
. 2024 Aug;
13(16).
PMID: 39201010
Adverse drug reactions are a significant problem in modern society, stemming from the increase in prescribed medications, over-the-counter drugs, and overall polypharmacy. Glomerular disorders are one of the frequently reported...
3.
Moledina D, Obeid W, Smith R, Rosales I, Sise M, Moeckel G, et al.
J Clin Invest
. 2024 Mar;
134(6).
PMID: 38488004
No abstract available.
4.
Krishnan N, Moledina D, Perazella M
Am J Kidney Dis
. 2024 Jan;
83(5):659-676.
PMID: 38243994
Toxic nephropathies are a clinically common group of disorders characterized by toxin-induced renal injury that can affect the glomerulus, vasculature, or tubulointerstitium. Various endogenous (eg, myoglobin, hemoglobin, monoclonal light chains,...
5.
6.
Kanbay M, Copur S, Yilmaz Z, Tanriover C, Hasbal N, Ortiz A, et al.
Eur J Intern Med
. 2023 Sep;
118:22-31.
PMID: 37741791
Cancer is the second leading cause of death among the adult population following cardiovascular diseases. Prevention and earlier diagnosis are among the cornerstones in the management of malignancies. Albuminuria is...
7.
8.
Moledina D, Obeid W, Smith R, Rosales I, Sise M, Moeckel G, et al.
J Clin Invest
. 2023 Jul;
133(13).
PMID: 37395276
BackgroundAcute tubulointerstitial nephritis (AIN) is one of the few causes of acute kidney injury with diagnosis-specific treatment options. However, due to the need to obtain a kidney biopsy for histological...
9.
Kanbay M, Copur S, Siriopol D, Yildiz A, Berkkan M, Popa R, et al.
Clin Kidney J
. 2023 May;
16(5):817-826.
PMID: 37151409
Background: Immune checkpoint inhibitors (ICPIs) are a novel therapeutic approach to cancer treatment that have changed the landscape of cancer therapy but also have some considerable drawbacks. Acute kidney injury...
10.
Davenport M, Perazella M, Nallamothu B
Circulation
. 2023 Mar;
147(11):847-849.
PMID: 36913495
No abstract available.